CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Dallas, Texas, United States and 80 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Dallas, Texas, United States and 125 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Dallas, Texas, United States and 43 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Mesquite, Texas, United States and 45 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Dallas, Texas, United States and 117 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Dallas, Texas, United States and 97 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
Dallas, Texas, United States and 44 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Dallas, Texas, United States and 67 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Dallas, Texas, United States and 141 other locations
This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Su...
Phase 3
Fort Worth, Texas, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal